Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
04/2003
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives
04/10/2003US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
04/10/2003US20030069249 Analgesics; central nervous system disorders
04/10/2003US20030069248 Antiinflammatory agents; controlling cell cycle
04/10/2003US20030069243 Novel substituted imidazole compounds
04/10/2003US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030069183 Lyophilized HGF preparations
04/10/2003US20030068664 Monitoring effectiveness of preferential cancer immunotherapy; obtain mammal, administer immunotherapy, evaluate effectiveness of treatment
04/10/2003CA2462795A1 Secreted proteins
04/10/2003CA2462538A1 Process for the fractionation of oilseed press cakes and meals
04/10/2003CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents
04/10/2003CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/10/2003CA2455225A1 Novel proteins and nucleic acids encoding same
04/09/2003EP1300468A2 TRNA synthetase
04/09/2003EP1300407A1 Carbamates derived from arylalkylamines
04/09/2003EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
04/09/2003EP1299727A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
04/09/2003EP1299545A2 Drug metabolizing enzymes
04/09/2003EP1299544A2 Fimh adhesin proteins and methods of use
04/09/2003EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
04/09/2003EP1299538A2 Secreted proteins
04/09/2003EP1299412A2 Protein modification and maintenance molecules
04/09/2003EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function
04/09/2003EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
04/09/2003EP1299374A1 Novel non-psychotropic cannabinoids
04/09/2003EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
04/09/2003EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
04/09/2003EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
04/09/2003EP1299102A2 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy
04/09/2003EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use
04/09/2003EP1299092A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel
04/09/2003EP1299010A1 Vitamin k and essential fatty acids
04/09/2003EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
04/09/2003EP0793492B1 Use of sclareolide for treating disorders characterised by excessive cell proliferation
04/09/2003CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder
04/09/2003CN1408438A Gene vaccine based on macrophage colony stimulating factor recepter and its use
04/09/2003CN1408425A New Chinese medicine for curing uraemia
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
04/09/2003CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor
04/08/2003US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
04/08/2003US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins
04/08/2003US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
04/08/2003US6544998 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
04/08/2003US6544991 Compositions and methods for treating bacterial infections
04/08/2003US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine
04/08/2003US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule
04/08/2003US6544541 Devices and compounds for treating arterial restenosis
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2049212C 6-substituted-tetrahydrobenz ¬cd| indoles
04/08/2003CA2048243C 4-amino- 4,6-steroids and their use as 5-.alpha.-reductase inhibitors
04/07/2003WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
04/03/2003WO2003027263A2 Proteins associated with cell growth, differentiation, and death
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003027111A1 Chemical compounds
04/03/2003WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors
04/03/2003WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors
04/03/2003WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors
04/03/2003WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors
04/03/2003WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors
04/03/2003WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
04/03/2003WO2003027091A1 Pyrane derivatives as both ace- and nep- inhibitors
04/03/2003WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
04/03/2003WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
04/03/2003WO2003026667A1 Quinazolino- and quinolino- guanidines as ligands for the neurop eptide ff (npff) receptors
04/03/2003WO2003026663A1 Process for making substituted pyrazoles
04/03/2003WO2003026622A1 Lisinopril compositions having large-particle dcpd
04/03/2003WO2003026579A2 Combination therapies for immune mediated diseases
04/03/2003WO2003026564A2 Pharmaceutical compositions for the treatment of urinary disorders
04/03/2003WO2003026408A1 Model animal with overexpression of regucalcin
04/03/2003WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2002073213A3 Assay
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002062330A3 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
04/03/2003WO2002057413A3 Peptides for activation and inhibition of delta pkc
04/03/2003WO2002044419A3 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003US20030065195 Ether compounds
04/03/2003US20030065023 Anticancer agents, viricides, psychological disorders
04/03/2003US20030064987 Immunology moderators; interleukin antagonist; anticancer agents
04/03/2003US20030064983 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders
04/03/2003US20030064966 Bone disorders; osteoporosis
04/03/2003US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
04/03/2003US20030064935 Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
04/03/2003US20030064933 Transdermal administration of ACE inhibitors
04/03/2003US20030064426 Expression vector for use in the treatment of cancer and age-related defects
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents
04/03/2003US20030064069 Specific binding members for TGFbeta1
04/03/2003US20030064068 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
04/03/2003CA2461731A1 Pharmaceutical compositions for the treatment of urinary disorders
04/03/2003CA2461666A1 Combination therapies for immune mediated diseases
04/03/2003CA2461363A1 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
1 ... 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 ... 562